Atalay, Selma <br/><br/>
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial.  [electronic resource] 

 -  JAMA dermatology  04 2020 
 - 393-400 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6084 
<br/><br/><label>Standard No.: </label>10.1001/jamadermatol.2019.4897  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--administration & dosage<br/>Adult<br/>Aged<br/>Biological Products--administration & dosage<br/>Dermatologic Agents--administration & dosage<br/>Drug Tapering<br/>Etanercept--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Prospective Studies<br/>Psoriasis--drug therapy<br/>Quality of Life<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Ustekinumab--administration & dosage